ZOSANO PHARMA
Zosano Pharma focuses on creating better products with its innovative drug delivery technology. Zosano's objective is to discover and develop therapeutic drug candidates that address large unmet medical needs or have a significant potential for commercialization. It was founded in 2006 and headquartered in Fremont, California.
ZOSANO PHARMA
Social Links:
Industry:
Biopharma Biotechnology Medical
Founded:
2006-10-01
Address:
Fremont, California, United States
Country:
United States
Website Url:
http://www.zosanopharma.com
Total Employee:
51+
Status:
Active
Contact:
(510) 745-1200
Email Addresses:
[email protected]
Total Funding:
271.92 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Google Universal Analytics Apache Microsoft Exchange Online
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Aisling Capital
Aisling Capital investment in Post-IPO Equity - Zosano Pharma
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Zosano Pharma
Nomura International
Nomura International investment in Debt Financing - Zosano Pharma
New Enterprise Associates
New Enterprise Associates investment in Debt Financing - Zosano Pharma
BioMed Ventures
BioMed Ventures investment in Debt Financing - Zosano Pharma
ProQuest Investments
ProQuest Investments investment in Series B - Zosano Pharma
Phase4 Ventures
Phase4 Ventures investment in Series B - Zosano Pharma
New Enterprise Associates
New Enterprise Associates investment in Series B - Zosano Pharma
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series B - Zosano Pharma
New Enterprise Associates
New Enterprise Associates investment in Series A - Zosano Pharma
Official Site Inspections
http://www.zosanopharma.com Semrush global rank: 3.82 M Semrush visits lastest month: 3.48 K
- Host name: ewhserver1302.edgewebhosting.net
- IP address: 69.63.140.80
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
